Diagnosis of Clostridium difficile-associated disease: Examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification

British Journal of Biomedical Science

Volumn 69, Issue 3, 2012, Pages 112-118

  Bamber, A I ^a   Fitzsimmons, Katie ^a   Cunniffe, J G ^a   Beasor, C C ^a   MacKintosh, C A ^a   Hobbs, G ^b  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Clostridium difficile; Glutamate dehydrogenase; Illumigene; Loop mediated isothermal amplification

Indexed keywords

GLUTAMATE DEHYDROGENASE; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM TOXIN;

ALGORITHM; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; GLUTAMATE DEHYDROGENASE ASSAY; LABORATORY DIAGNOSIS; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TOXIN ANALYSIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CULTURE TECHNIQUE; FECES; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; INTERMETHOD COMPARISON; TURNAROUND TIME;

ALGORITHMS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CELL CULTURE TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENTEROTOXINS; FECES; GLUTAMATE DEHYDROGENASE; HUMANS; IMMUNOENZYME TECHNIQUES; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84868647750     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2012.12069136     Document Type: Article

References (58)

1. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 45 (10): 758-64. (Pubitemid 351650356)
2. Cookson B. Hypervirulent strains of Clostridium difficile. Postgrad Med J 2007; 83 (979): 291-5. (Pubitemid 46797823)
3. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004; 171 (1): 51-8. (Pubitemid 38925121)
4. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342 (6): 390-7. (Pubitemid 30084537)
5. Wilcox MH. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 2003; 17 (3): 475-93.
6. Debast SB, Vaessen N, Choudry A, Wiegers LEAJ, Van den Berg RJ, Kuijper EJ. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect 2009; 15 (5): 427-34.
7. Jamal W, Rotimi VO, Brazier J, Duerden BI. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Anaerobe 2010; 16 (6): 560-5.
8. Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 2007; 13 (3): 485-7. (Pubitemid 46348139)
9. Dawson LF, Valiente E, Wren BW. Clostridium difficile - a continually evolving and problematic pathogen. Infect Genet Evol 2009; 9 (6): 1410-7.
10. McFarland LV, Beneda HW, Clarridge JE, Raugi GJ. Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control 2007; 35 (4): 237-53. (Pubitemid 46670518)
11. Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Gut 2008; 57 (6): 850-60. (Pubitemid 351716982)
12. Owens RC. Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2006; 26 (3): 299-311.
13. Planche T, Arnold A. Clostridium difficile. Medicine 2009; 37 (12): 641-3.
14. O'Connor KA, Kingston M, O'Donovan M, Cryan B, Twomey C, O'Mahony D. Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM 2004; 97 (7): 423-9. (Pubitemid 38967416)
15. Kim JW, Lee KL, Jeong JB et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium difficile-associated diarrhea. World J Gastroenterol 2010; 16 (28): 3573-7.
16. Department of Health and Health Protection Agency. Clostridium difficile infection: how to deal with the problem. London: DH/HPA, 2008 (www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-093220).
17. Poxton IR. Clostridium difficile. J Med Microbiol 2008; 57 (Pt 6): 683-4. (Pubitemid 351842057)
18. Bauer MP, Notermans DW, Benthem BHB et al.; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377 (9759): 63-73.
19. de Boer ED, Zwartkruis-Nahuis A, Heuvelink AE, Harmanus C, Kuijper EJ. Prevalence of Clostridium difficile in retailed meat in The Netherlands. Int J Food Microbiol 2011; 144 (3): 561-4.
20. Dubberke E, Reske K, Noble-Wang J et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007; 35 (5): 315-8. (Pubitemid 46907328)
21. Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL. Peripartum Clostridium difficile: case series and review of literature. Am J Obstet Gynecol 2008; 199 (4): 332-7.
22. Goldenberg SD, Cliff PR, Smith S, Milner M, French GL. Twostep glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 2010; 74 (1): 48-54.
23. Keel MK, Songer JG. The comparative pathology of Clostridium difficile-associated disease. Vet Pathol 2006; 43 (3): 225-40.
24. MacCannell DR, Lowie TJ, Gregson DB et al. Molecular analysis of C. difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 2006; 44 (6): 2147-52. (Pubitemid 43902167)
25. Vinh DC. Strains and toxins of Clostridium. CMAJ 2005; 172 (3): 312-3.
26. Gilligan PH. Is a two-step glutamate dehyrogenase antigency-totoxicity neutralization assay algorithm superior to the Premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J Clin Microbiol 2008; 46 (4): 1523-5. (Pubitemid 351563608)
27. Johnson AP. New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile. Expert Opin Ther Pat 2010; 20 (10): 1389-99.
28. Bobulsky G, Al-Nassir W, Riggs M, Sethi A, Donskey C. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008; 46 (3): 447-50. (Pubitemid 351263530)
29. Burns DA, Heap JT, Minton NP. Clostridium difficile spore germination: an update. Res Microbiol 2010; 161 (9): 730-4.
30. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467 (7316): 711-3.
31. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18 (2): 247-63. (Pubitemid 40548293)
32. Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 2008; 32 (3): 541-55. (Pubitemid 351538749)
33. Pelleschi ME. Clostridium difficile-associated disease: diagnosis, prevention, treatment, and nursing care. Crit Care Nurse 2008; 28 (1): 27-35.
34. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330 (4): 257-62. (Pubitemid 24034138)
35. Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010; 58 (8): 1556-64.
36. Cooke RP, Collins J, Galloway A, Holland D, Trigg G. Audit of the laboratory diagnosis of Clostridium difficile infection in the UK. J Hosp Infect 2010; 75 (4): 282-6.
37. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol 2008; 46 (11): 3686-9.
38. Shetty N, Wren MWD, Coen PG. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: meta-analysis. J Hosp Infect 2010; 77 (1): 1-6.
39. Wilkins TD, Lyerly DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 2003; 41: 531-4. (Pubitemid 36184156)
40. Wren MWD, Sivapalan M, Kinson R, Shetty NP. Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory. Br J Biomed Sci 2009; 66 (1): 1-5.
41. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009; 47 (10): 3211-7.
42. Pratt RJ, Pellowe CM, Wilson JA et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 (Suppl 1): S1-64.
43. Department of Health. Updated guidance on the diagnosis and reporting of Clostridium difficile. London: DH, 2012 (www.dh.gov.uk//publications).
44. Arnold A, Pope C, Bray S et al. Prospective assessment of twostage testing for Clostridium difficile. J Hosp Infect 2010; 76 (1): 18-22.
45. Wilcox MH, Coia J, Planche T; CDI Diagnosis Working Group. Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI), 2009 (www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1238055363795).
46. Novak-Weekley SM, Marlowe EM, Miller JM et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48 (3): 889-93.
47. Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010; 48 (2): 606-8.
48. Kato H, Yokoyama T, Kato H, Arakawa Y. Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification. J Clin Microbiol 2005; 43 (12): 6108-12. (Pubitemid 43100667)
49. Parida M, Sannarangaiah S, Dash KP, Rao PVL, Morita K. Loop-mediated isothermal amplification (LAMP): a new generation of innovative gene amplification techniques; perspectives in clinical diagnosis of infectious diseases. Rev Med Virol 2008; 18 (6): 407-21.
50. Boehme CC, Nabeta P, Henostroza G et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007; 45 (6): 1936-40. (Pubitemid 46933929)
51. Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies - a review. Nucleosides, Nucleotides Nucleic Acids 2008; 27 (3): 224-43. (Pubitemid 351220650)
52. Yamazaki W, Ishibashi M, Kawahara R, Inoue K. Development of a loop-mediated isothermal amplification assay for sensitive and rapid detection of Vibrio parahaemolyticus. BMC Microbiol 2008; 8: 163.
53. Department of Health. The Health and Social Care Act 2008: Code of Practice for the NHS on the prevention and control of healthcare-associated infections and related guidance. London: DH, 2008 (www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-081927).
54. Schmidt ML, Gilligan PH. Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe 2009; 15 (6): 270-3.
55. Calfee DP. Clostridium difficile: a reemerging pathogen. Geriatrics 2008; 63 (9): 10-21.
56. Planche T, Aghaizu A, Holliman R et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008; 8 (12): 777-84.
57. Adalja AA, Kellum JA. Clostridium difficile: moving beyond antimicrobial therapy. Crit Care 2010; 14 (5): 320.
58. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996; 34 (1): 23-30. (Pubitemid 26313206)